Apremilast, brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. It may also be useful for other immune system related inflammatory diseases. The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4) and inhibits spontaneous production of TNF-alpha from human rheumatoid synovial cells.It is taken by mouth.
This report elaborates the market size, market characteristics, and market growth of the Apremilast (CAS 608141-41-9) industry, and breaks down according to the type, application, and consumption area of Apremilast (CAS 608141-41-9). The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Also Read: http://www.marketwatch.com/story/apremilast-cas-608141-41-9-market-...
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Apremilast (CAS 608141-41-9) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Apremilast (CAS 608141-41-9) market covered in Chapter 13:
AChemBlock
DR REDDYS LABORATORIES LTD
Lupin Ltd
Cayman Chemical
Mehta API Pvt. Ltd.
Otezla
Lewens Labs
Hangzhou Longshine Bio-Tech Co., Ltd
Intas Pharmaceuticals
Zhejiang Ausun Pharmaceutical
In Chapter 6, on the basis of types, the Apremilast (CAS 608141-41-9) market from 2015 to 2025 is primarily split into:
Solid
Liquid
Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-fixed-s...
In Chapter 7, on the basis of applications, the Apremilast (CAS 608141-41-9) market from 2015 to 2025 covers:
Psoriasis
Psoriatic arthritis
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-paving-...
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-nail-sa...
List OF CONTENTS AND TABLES:
1 Apremilast (CAS 608141-41-9) Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Apremilast (CAS 608141-41-9) Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-column-...
3 Apremilast (CAS 608141-41-9) Market Forces
3.1 Global Apremilast (CAS 608141-41-9) Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Apremilast (CAS 608141-41-9) Market - By Geography
4.1 Global Apremilast (CAS 608141-41-9) Market Value and Market Share by Regions
4.1.1 Global Apremilast (CAS 608141-41-9) Value ($) by Region (2015-2020)
4.1.2 Global Apremilast (CAS 608141-41-9) Value Market Share by Regions (2015-2020)
4.2 Global Apremilast (CAS 608141-41-9) Market Production and Market Share by Major Countries
4.2.1 Global Apremilast (CAS 608141-41-9) Production by Major Countries (2015-2020)
4.2.2 Global Apremilast (CAS 608141-41-9) Production Market Share by Major Countries (2015-2020)
4.3 Global Apremilast (CAS 608141-41-9) Market Consumption and Market Share by Regions
4.3.1 Global Apremilast (CAS 608141-41-9) Consumption by Regions (2015-2020)
4.3.2 Global Apremilast (CAS 608141-41-9) Consumption Market Share by Regions (2015-2020)
5 Apremilast (CAS 608141-41-9) Market - By Trade Statistics
5.1 Global Apremilast (CAS 608141-41-9) Export and Import
5.2 United States Apremilast (CAS 608141-41-9) Export and Import (2015-2020)
5.3 Europe Apremilast (CAS 608141-41-9) Export and Import (2015-2020)
5.4 China Apremilast (CAS 608141-41-9) Export and Import (2015-2020)
5.5 Japan Apremilast (CAS 608141-41-9) Export and Import (2015-2020)
5.6 India Apremilast (CAS 608141-41-9) Export and Import (2015-2020)
5.7 ...
6 Apremilast (CAS 608141-41-9) Market - By Type
6.1 Global Apremilast (CAS 608141-41-9) Production and Market Share by Types (2015-2020)
6.1.1 Global Apremilast (CAS 608141-41-9) Production by Types (2015-2020)
6.1.2 Global Apremilast (CAS 608141-41-9) Production Market Share by Types (2015-2020)
6.2 Global Apremilast (CAS 608141-41-9) Value and Market Share by Types (2015-2020)
6.2.1 Global Apremilast (CAS 608141-41-9) Value by Types (2015-2020)
6.2.2 Global Apremilast (CAS 608141-41-9) Value Market Share by Types (2015-2020)
6.3 Global Apremilast (CAS 608141-41-9) Production, Price and Growth Rate of Solid (2015-2020)
6.4 Global Apremilast (CAS 608141-41-9) Production, Price and Growth Rate of Liquid (2015-2020)
7 Apremilast (CAS 608141-41-9) Market - By Application
7.1 Global Apremilast (CAS 608141-41-9) Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Apremilast (CAS 608141-41-9) Consumption by Applications (2015-2020)
7.1.2 Global Apremilast (CAS 608141-41-9) Consumption Market Share by Applications (2015-2020)
7.2 Global Apremilast (CAS 608141-41-9) Consumption and Growth Rate of Psoriasis (2015-2020)
7.3 Global Apremilast (CAS 608141-41-9) Consumption and Growth Rate of Psoriatic arthritis (2015-2020)
8 North America Apremilast (CAS 608141-41-9) Market
8.1 North America Apremilast (CAS 608141-41-9) Market Size
8.2 United States Apremilast (CAS 608141-41-9) Market Size
8.3 Canada Apremilast (CAS 608141-41-9) Market Size
8.4 Mexico Apremilast (CAS 608141-41-9) Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Apremilast (CAS 608141-41-9) Market Analysis
9.1 Europe Apremilast (CAS 608141-41-9) Market Size
9.2 Germany Apremilast (CAS 608141-41-9) Market Size
9.3 United Kingdom Apremilast (CAS 608141-41-9) Market Size
9.4 France Apremilast (CAS 608141-41-9) Market Size
9.5 Italy Apremilast (CAS 608141-41-9) Market Size
9.6 Spain Apremilast (CAS 608141-41-9) Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Apremilast (CAS 608141-41-9) Market Analysis
10.1 Asia-Pacific Apremilast (CAS 608141-41-9) Market Size
10.2 China Apremilast (CAS 608141-41-9) Market Size
10.3 Japan Apremilast (CAS 608141-41-9) Market Size
10.4 South Korea Apremilast (CAS 608141-41-9) Market Size
10.5 Southeast Asia Apremilast (CAS 608141-41-9) Market Size
10.6 India Apremilast (CAS 608141-41-9) Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Apremilast (CAS 608141-41-9) Market Analysis
11.1 Middle East and Africa Apremilast (CAS 608141-41-9) Market Size
11.2 Saudi Arabia Apremilast (CAS 608141-41-9) Market Size
11.3 UAE Apremilast (CAS 608141-41-9) Market Size
11.4 South Africa Apremilast (CAS 608141-41-9) Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Apremilast (CAS 608141-41-9) Market Analysis
12.1 South America Apremilast (CAS 608141-41-9) Market Size
12.2 Brazil Apremilast (CAS 608141-41-9) Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 AChemBlock
13.1.1 AChemBlock Basic Information
13.1.2 AChemBlock Product Profiles, Application and Specification
13.1.3 AChemBlock Apremilast (CAS 608141-41-9) Market Performance (2015-2020)
13.2 DR REDDYS LABORATORIES LTD
13.2.1 DR REDDYS LABORATORIES LTD Basic Information
13.2.2 DR REDDYS LABORATORIES LTD Product Profiles, Application and Specification
13.2.3 DR REDDYS LABORATORIES LTD Apremilast (CAS 608141-41-9) Market Performance (2015-2020)
13.3 Lupin Ltd
13.3.1 Lupin Ltd Basic Information
13.3.2 Lupin Ltd Product Profiles, Application and Specification
13.3.3 Lupin Ltd Apremilast (CAS 608141-41-9) Market Performance (2015-2020)
13.4 Cayman Chemical
13.4.1 Cayman Chemical Basic Information
13.4.2 Cayman Chemical Product Profiles, Application and Specification
13.4.3 Cayman Chemical Apremilast (CAS 608141-41-9) Market Performance (2015-2020)
13.5 Mehta API Pvt. Ltd.
13.5.1 Mehta API Pvt. Ltd. Basic Information
13.5.2 Mehta API Pvt. Ltd. Product Profiles, Application and Specification
13.5.3 Mehta API Pvt. Ltd. Apremilast (CAS 608141-41-9) Market Performance (2015-2020)
13.6 Otezla
13.6.1 Otezla Basic Information
13.6.2 Otezla Product Profiles, Application and Specification
13.6.3 Otezla Apremilast (CAS 608141-41-9) Market Performance (2015-2020)
13.7 Lewens Labs
13.7.1 Lewens Labs Basic Information
13.7.2 Lewens Labs Product Profiles, Application and Specification
13.7.3 Lewens Labs Apremilast (CAS 608141-41-9) Market Performance (2015-2020)
13.8 Hangzhou Longshine Bio-Tech Co., Ltd
13.8.1 Hangzhou Longshine Bio-Tech Co., Ltd Basic Information
13.8.2 Hangzhou Longshine Bio-Tech Co., Ltd Product Profiles, Application and Specification
13.8.3 Hangzhou Longshine Bio-Tech Co., Ltd Apremilast (CAS 608141-41-9) Market Performance (2015-2020)
13.9 Intas Pharmaceuticals
13.9.1 Intas Pharmaceuticals Basic Information….….continued

CONTACT DETAILS :
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105